Coronavirus-clinical-updates
American Academy of Neurology (AAN) Journal:
Novel coronavirus disease
(COVID-19) has been suggested to not only affect health during the acute phase
of the SARS-CoV-2 infection, but some manifestations have been consistently
reported also after the recovery. Such phenomenon has been named “long-COVID”
or “post-acute COVID-19”.
These...
The human
pancreas is a target of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). New-onset hyperglycaemia and insulin resistance have been
reported in patients with coronavirus disease-2019 (Covid-19) without history
of diabetes.
However,
it is unclear whether such metabolic alterations are transient or whether
individu...
American Academy of Pediatric Journal:
TAKE-HOME MESSAGE
This retrospective cohort study
looked at the association between asthma and SARS-CoV-2 infection risk in
children aged 5 to 17 years. Children who had asthma were more likely to be
tested for SARS-CoV-2 infection than those without asthma.
However, the infection rates among...
Urinary
tract infections (UTIs) represent a common pathology among female patients,
leading to overprescribing antibiotics, globally. The emergence of the COVID-19
pandemic has dramatically increased the incidence of this particular viral
pneumonia with secondary bacterial superinfection, resulting in continuous
therapeutic or prophylactic...
Nature Medicine
Post-acute
sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)—can
involve the pulmonary and several extrapulmonary organs, including the
cardiovascular system. A few studies have investigated cardiovascular outcomes
in the post-acute phase of the COVID-19; however, most were limited to
hospitalized...
Children who are infected with
COVID-19 are at a higher risk of developing diabetes, according to a new study
by the Centers for Disease Control and Prevention (CDC). Increased incidence of
diabetes seen among patients aged younger than 18 years after acute COVID-19
infection versus those without COVID-19.
Key Summary
What is already...
Comparing COVID-19 variants (Delta vs. Omicron) RemoveAvailable Brand
The U.S. Centers for Disease
Control and Prevention announced that the recommended isolation time for
people with COVID-19 is now reduced from
10 to 5 days for those who are asymptomatic.
The agency said that people who test
positive should isolate for 5 (five) days, and if they are asymptomatic, or
their symptoms are resolving (without fe...
COVID-19
may elevate the risk of hyperglycemia and other complications in patients with
and without prior diabetes history. Individuals
with preexisting diabetes show higher incidence of COVID-19 illness and poorer
prognosis upon infection. Likewise, an increased frequency of diabetes onset
and diabetes complications has been reported in patie...
TAKE-HOME MESSAGE
Patients who are hospitalized with COVID-19 have
been shown to have a high risk of thromboembolic events post discharge. In
this open-label randomized trial, the authors showed that, in high-risk
patients who are hospitalized for COVID-19, the use of thromboprophylaxis
and rivaroxaban for 35 days after di...
The World Health Organization announced
Friday it has designated the newly identified coronavirus variant, B.1.1.529,
as a variant of concern, named Omicron.The new Omicron variant was first
reported to the WHO from South Africa on 24 November, 2021. It has also been
identified in Botswana, Belgium, Hong Kong and Israel. It appears to be spread...
Vitamin D deficiency is one of
the most prevalent micronutrient deficiencies in the world. It has emerged as a
public health problem in many developing countries of the world including Bangladesh.
Over a billion people worldwide are vitamin D deficient. The worldwide
prevalence of vitamin D deficiency is 30-50% among children and even higher in...
